Terumo Corporation

Equities

Market Closed - Japan Exchange Other stock markets 11:53:37 18/05/2026 am IST			5-day change	1st Jan Change
2,275.00 ^JPY	+18.37%		+16.25%	+0.22%

08:06am	Japan's Nikkei slips for third day as global bond selloff, Mideast war weigh	RE
15/05	Terumo's Profit Rises 16% Fiscal Year 2025	MT

Published on 11/12/2025 at 03:20 pm IST - Modified on 11/13/2025 at 01:22 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

[Interpreted] Thank you for joining today's. We will be starting our financial announcement. So I'd like to first ask CFO, Hagimoto-san to talk. Then

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

08:06am	Japan's Nikkei slips for third day as global bond selloff, Mideast war weigh	RE
15/05	Terumo's Profit Rises 16% Fiscal Year 2025	MT
15/05	Terumo Corporation, 2026 Earnings Call, May 15, 2026
15/05	Terumo Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
22/04	Humacyte, Inc. Announces the Appointment of Jim Mercadante as Chief Commercial Officer	CI
09/04	Terumo Deepens Costa Rica Investment Amid Medtech Growth	MT
19/03	Tata Elxsi and Terumo Corporation Launch Global Offshore Development Center	CI
19/03	Tata Elxsi launches global offshore development center for Terumo Corporation	RE
02/03	Shoulder Innovations, Inc. Announces Board and Committee Changes, Effective February 26, 2026	CI
25/02	Galderma Announces Triple Approval of New Restylane Syringe in the EU, the U.S., and Canada	CI
13/02	Terumo Corporation, Q3 2026 Earnings Call, Feb 13, 2026
13/02	Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025	CI
10/02	New purchases in the Asia-Pacific Investor portfolio
13/01	Terumo Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 05:15 PM
06/01	Terumo launches Surtract(TM) safety syringe in the United States	RE